Outcomes of the Evans Calcaneal Lengthening Based on Bone Grafting Material
1 other identifier
observational
20
1 country
1
Brief Summary
The Evans calcaneal lengthening is a common surgical correction used for children with spastic cerebral palsy (CP) and painful flat feet. This procedure involves the insertion of a trapezoidal bone graft into the calcaneus bone. Both autograft and allografting materials have been used for this procedure, but both types of grafting materials have associated limitations. Autologous grafting materials, which are harvested from the iliac crest at the time of surgery, are associated with high rates of prolonged donor site pain. There is limited bone available from the iliac crest. For this reason autologous bone grafts are not commonly used for the Evan's procedure. Cadaver allografting materials are variable in their mechanical and geometric properties. Recently, xenografting materials have been developed that have consistent mechanical properties and are available in a larger size that is formed to fit the individual patient intraoperatively. The purpose of this study is to evaluate the long term outcomes of the procedure with the different graft options. Another purpose is to compare the difference in surgical correction obtained with the cadaver allograft and the xenografting materials. This study will also observe and evaluate a wide range of outcome variables that encompass multiple levels of patient care, from clinical observation to parent and patient satisfaction, and compare these with the observed changes in the radiographic and plantar pressure parameters of the foot. This data will be evaluated pre to post surgery and for two years of follow-up time. The aim is to uncover the characteristics of collapse observed with the two different grafting materials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 26, 2014
CompletedFirst Posted
Study publicly available on registry
March 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 27, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 27, 2018
CompletedApril 30, 2021
April 1, 2021
8.2 years
February 26, 2014
April 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the amount of collapse
Measurement on radiographs of distance between heme clips located in calcaneous bone of the foot. Within the patient's own calcaneous bone, a heme clip will be placed on each side of the osteotomy. From post-operative radiographs, the amount of collapse will be determined by measuring the distance from one heme clip to the other. Post-operative changes in the distance between the clips from the first radiograph after surgery (used as a baseline, usually 6 weeks after surgery) indicate collapse of the graft.
Pre-operatively (3-12 months), 6 weeks, 6 months, and 1 and 2 years post-operatively
Secondary Outcomes (1)
Change in Plantar pressures
Pre-operatively (3-12 months), then 1 and 2 years post-operatively
Other Outcomes (1)
Change in Health related quality of life
Pre-operativey (3-12 months), then at 6 months, 1 and 2 years post-operatively
Study Arms (2)
Bovine Xenograft
Patients in this group received a bovine xenograft in their Evans calcaneal lengthening procedure. Up until April 2014, patients were randomized into receiving the bovine graft or allograft. However, the bovine xenograft will no longer be manufactured, so no future patients will receive the bovine xenograft during the procedure.
Iliac Crest Allograft
Patients in this group received an iliac crest cadaver allograft (bicortical or tricortical) in their Evans calcaneal lengthening procedure. Up until April 2014, patients were randomized into receiving the bovine graft or allograft. However, the bovine xenograft will no longer be manufactured, so all future patients will receive the allograft during the procedure.
Eligibility Criteria
Children receiving an Evans calcaneal lengthening procedure at Children's Hospital Colorado.
You may qualify if:
- Diagnosis of spastic CP or similar neuromuscular disorder
- Surgical correction of pes planovalgus, through the Evans calcaneal lengthening
- Age 4-18 years old
- Gross Motor Function Classification System (GMFCS) 1-4
- Children who are ambulatory or non-ambulatory and able to stand for plantar pressures
- Children who have or will have a first metatarsal osteotomy at the foot
You may not qualify if:
- Concomitant bony surgical procedures at the foot either before or concomitantly with the Evans procedure
- Gross Motor Function Classification System (GMFCS) level of 5
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frank M Chang, MD
Children's Hospital Colorado
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2014
First Posted
March 3, 2014
Study Start
September 1, 2010
Primary Completion
November 27, 2018
Study Completion
November 27, 2018
Last Updated
April 30, 2021
Record last verified: 2021-04